Diagnosing Molecular QTL Results And Technical Artifacts

Why Diagnose a Molecular QTL Result?

A small association p-value is not a substitute for checking whether the data and model tell a coherent story. A single unusual sample, a nonlinear genotype pattern, changing residual variance, or a technical covariate aligned with genotype can make a molecular QTL result look more convincing than it is. Diagnostics help identify these patterns; they do not, by themselves, prove that a signal is biological or determine which samples should be removed.

For a continuous, processed molecular phenotype, a basic association model is linear regression. Let \(y_i\) be the phenotype for donor \(i\), \(g_i\) the genotype dosage, and \(c_i\) the vector of included covariates. The dosage is commonly coded as 0, 1, or 2 copies of a specified allele. The fitted model is

y_i=\beta_0+\beta_G g_i+\boldsymbol{\gamma}^{\mathsf T}c_i+\varepsilon_i.

Here \(\beta_G\) is the conditional change in expected phenotype per additional allele copy, holding the included covariates fixed. The usual linear-model interpretation assumes the conditional mean is correctly specified, the residuals are independent across donors (or their dependence is modeled), and residual variance is appropriately handled. Normal residuals are additionally needed for exact small-sample \(t\)-based inference, not for calculating a fitted line. Diagnostics examine whether the data make these assumptions plausible.

Definition: A QTL diagnostic is a plot, summary, or sensitivity check used to assess the fit and reliability of a genotype–phenotype association model. It can reveal patterns such as influential observations, nonlinearity, nonconstant residual variance, or technical structure. A diagnostic is evidence to investigate, not an automatic rule for accepting or rejecting a result.

Start With the Genotype–Phenotype Pattern

Plot phenotype against genotype before relying on a single regression statistic. For dosage data, display the observations at dosages 0, 1, and 2 using jitter, and show genotype-specific sample sizes and summaries. Group means, medians, and spreads can reveal an apparent trend driven by one genotype class or one extreme value. If genotypes are treated as categories, a boxplot or separate distributions can show patterns that an additive dosage model may conceal.

The additive model assumes a linear change in the conditional mean with dosage: the expected difference from dosage 0 to 1 is the same as the difference from 1 to 2. The plot does not establish that this assumption is true, but it makes marked departures visible. Include covariates in the model as appropriate; raw group summaries are descriptive and may reflect covariate imbalance rather than a conditional genotype association.

Worked Example: An Association Driven by One Observation

Suppose a hypothetical study measures a processed expression phenotype in six donors. The observed dosage–phenotype pairs are \((0,2),(0,3),(1,3),(1,4),(2,4),(2,12)\), with phenotype measured in arbitrary normalized units. The genotype-specific means are \(2.5\), \(3.5\), and \(8.0\) units for dosages 0, 1, and 2. The dosage-2 mean is notably affected by the value 12.

For the unadjusted additive regression, \(\bar{g}=1\), \(\bar{y}=28/6=4.667\), and

\hat{\beta}_G= \frac{\sum_i(g_i-\bar{g})(y_i-\bar{y})}{\sum_i(g_i-\bar{g})^2} =\frac{11}{4}=2.75.

The numerator is 11: dosage-0 observations contribute \(-5\), dosage-1 observations contribute 0, and dosage-2 observations contribute 16. The denominator is 4. Thus the fitted association is 2.75 phenotype units per dosage copy. This estimate describes the full set of six observations, but the plot and group means suggest it may be highly sensitive to the donor with phenotype 12.

As a sensitivity calculation, omit that donor temporarily and refit; this is not a recommendation to discard the observation. For the remaining five donors, \(\bar{g}=0.8\), \(\bar{y}=3.2\), \(\sum(g_i-\bar{g})^2=2.8\), and \(\sum(g_i-\bar{g})(y_i-\bar{y})=2.2\). Therefore,

\hat{\beta}_{G,\text{without}}=\frac{2.2}{2.8}=0.786.

The large change from 2.75 to 0.786 units per dosage copy flags sensitivity to one observation. The correct next step is to investigate its genotype call, phenotype measurement, sample identity, and relevant technical records, then report a justified analysis and sensitivity results. A large residual or influential observation is not, by itself, evidence that the data point is erroneous.

Residual Checks for Model Misspecification

For each donor, the fitted value is the model’s predicted phenotype, and the residual is the observed phenotype minus that fitted value. A residual-versus-fitted plot should be inspected for systematic curvature, changing spread, clusters, or isolated points. A roughly patternless cloud is compatible with a reasonable mean specification and approximately constant residual variance; it cannot prove either condition. A normal quantile plot compares ordered residuals with the pattern expected under a normal distribution and can reveal strong skewness or heavy tails, particularly relevant to small-sample inference.

In QTL analysis, residual plots can also be stratified or colored by genotype, batch, processing date, or another technical variable. This can reveal a structure that is hidden in an overall plot. If the conditional mean is curved across dosage, for example, residuals from the additive model may show a systematic genotype pattern. If spread increases with fitted value or differs by genotype, the conventional constant-variance standard error may be unreliable.

Worked Example: A Dosage Pattern the Additive Model Misses

Consider a hypothetical phenotype measured in six donors: two observations at each dosage, with values \((0,0)\), \((0,0)\), \((1,4)\), \((1,4)\), \((2,0)\), and \((2,0)\). The genotype-specific means are 0, 4, and 0 units. This pattern peaks at the heterozygote rather than changing steadily with dosage.

For the additive regression, \(\bar{g}=1\) and \(\bar{y}=8/6=1.333\). The cross-product in the slope numerator is zero: the dosage-0 values contribute zero after centering, the two dosage-1 values have centered dosage zero, and the dosage-2 values are also zero. The fitted slope is therefore \(0/4=0\) units per dosage copy, and the fitted value for every donor is 1.333 units.

The residuals are \(-1.333,-1.333,2.667,2.667,-1.333,-1.333\) units, in dosage order. When plotted against genotype or fitted value, they form a clear pattern rather than a patternless cloud. The additive slope alone misses the strong genotype-specific difference. This diagnostic indicates that the additive mean model may be inadequate; it does not establish the mechanism of the pattern or justify a particular alternative without further analysis.

Technical Covariates and Artifact-Driven Signals

Technical variables such as assay batch, sequencing lane, plate, RNA quality, library size, or processing date can be associated with phenotype. They can also be unevenly distributed across genotype groups. Check plots and summaries of the phenotype by technical covariate and of genotype by technical covariate. For a categorical batch, display genotype counts and phenotype distributions within each batch. For a continuous quality measure, inspect its relationship with phenotype and genotype, and consider whether the fitted model accounts for it appropriately.

A technical association with phenotype does not automatically mean that a QTL is artifactual: the covariate may be unrelated to genotype, and the model may already account for it. The risk is greatest when technical variation and genotype are associated and the analysis fails to represent that structure adequately. Conversely, adding every recorded technical variable without considering the design can make estimates unstable or change the scientific question. Covariate choice should reflect the study design and the confounding principles used in QTL modeling.

Why confounding can create an apparent slope: In a simplified model \(y_i=\beta_0+\beta_Gg_i+\gamma z_i+\varepsilon_i\), where \(z_i\) is a technical variable, the slope from regressing \(y\) on \(g\) alone has expected value

\beta_G+\gamma\frac{\operatorname{Cov}(g,z)}{\operatorname{Var}(g)},

when the relevant variances exist and the linear model is appropriate. The added term is nonzero when the technical variable affects phenotype and covaries with genotype. Thus a marginal association can differ from the genotype association conditional on the technical variable. This identity explains why plotting both genotype and technical structure is useful; it does not decide which covariates should be adjusted for in a particular study.

Worked Example: A Batch-Aligned Genotype Pattern

Imagine eight hypothetical samples processed in two batches. Batch A has dosages \(0,0,1,1\), and every phenotype is 1 unit. Batch B has dosages \(1,2,2,2\), and every phenotype is 5 units. These values are deliberately simple to make the design pattern visible.

Without batch in the model, the mean dosage is \(9/8=1.125\), the mean phenotype is \(3\) units, \(\sum g_i^2=15\), and \(\sum g_i y_i=37\). Therefore,

\hat{\beta}_G= \frac{\sum g_i y_i-n\bar{g}\bar{y}}{\sum g_i^2-n\bar{g}^2} =\frac{37-8(1.125)(3)}{15-8(1.125)^2} =\frac{10}{4.875}=2.051

units per dosage copy. A plot of phenotype against dosage would show an apparent increase, but batch and phenotype are perfectly aligned: all Batch A samples have phenotype 1, and all Batch B samples have phenotype 5. The dosage distributions also differ between batches.

A model with a batch indicator and dosage assigns the 4-unit difference to batch and has a genotype coefficient of 0 for these data. However, there is no within-batch phenotype variation here, so the example cannot support a useful estimate of residual variance or a conventional significance test. Its point is diagnostic: the unadjusted association is compatible with technical structure, and the design must provide enough overlap to distinguish batch from genotype reliably. In real data, inspect that overlap rather than assuming an adjusted model can resolve a confounded design.

A Practical Diagnostic Sequence

Diagnostics are most informative when they are considered together and tied to a specific model. A useful sequence is:

Inspect the data and the association plot.
Check sample counts by genotype, genotype-specific phenotype summaries, and whether a small number of observations dominate the visible trend.

Examine model residuals.
Plot residuals against fitted values and genotype, and inspect a normal quantile plot when distributional assumptions matter for inference.

Check technical structure and overlap.
Compare genotype frequencies and phenotype distributions across relevant technical groups or quality measures. Identify whether the model can separate their contributions.

Investigate, then perform justified sensitivity checks.
Review sample and assay records for suspicious observations. Compare results under defensible specifications and document changes; do not remove samples solely to improve a p-value.

Common Pitfalls and Interpretation

Treating a diagnostic plot as a hypothesis test. A plot can reveal a pattern but does not give a calibrated probability that a model is correct. Use it to identify concerns and guide appropriate checks.
Removing an outlier because it weakens the result. Exclusion needs a data-quality or prespecified methodological justification, not a desired association statistic. Report the impact of defensible sensitivity analyses.
Assuming a significant association validates the model. Statistical significance does not rule out technical confounding, influential observations, or a misspecified genotype–phenotype relationship.
Adjusting for a technical variable without checking the design. If genotype and batch have little or no overlap, their effects may not be separately identifiable. No regression adjustment can recover information the study design does not contain.
Reading raw genotype-group means as adjusted effects. Group summaries are useful diagnostics, but they do not account for covariates or other modeled structure. Interpret them alongside the fitted model and its assumptions.

A credible molecular QTL result is supported by a coherent genotype–phenotype pattern, residual behavior compatible with the chosen model, and no unexamined technical structure that could explain the association. Diagnostics do not certify causality; they help determine whether the reported association is robust enough to interpret and investigate further.

Check Your Understanding

Use the diagnostic principles to answer the following questions.

What pattern in genotype-stratified phenotype summaries might suggest that an additive dosage model is inadequate?
A QTL slope changes substantially when one sample is omitted in a sensitivity check. What should be investigated before deciding whether to exclude that sample?
Why can a technical covariate that affects phenotype create an apparent genotype association when it is correlated with genotype?
What does a curved pattern in residuals across genotype dosage suggest, and what does it not establish?
If batch and genotype have little overlap in a study, why might including batch in a regression fail to resolve their separate contributions?